Marketing’s Profound Role In Diversifying Clinical Trials

As healthcare information has achieved ubiquity in our lives, so, too, have reports about clinical trials of new, potentially lifesaving drugs. There are, in fact, three conversations happening at once about clinical trials. One is on the clinical side, and in these discussions the talk is about protocols and data, crossover design, arms and controls. It is technical and expertise-based.

Read More